FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to endocrinology, and concerns treating neuropathic trophic ulcers accompanying diabetic foot. That is ensured by an integrated treatment including administering Oktolipene and Sulodexide intravenously, then orally, as well as administering Konvalis in paraesthesias and pains in calves and feet. That is combined with applications of the preparation Acerbin on the ulcerous defect until the ulcerous-wound defect gets cleaned completely. That is followed by implanting collagen into the bottom and walls of the defect with closing the wound surface with an antiseptic.
EFFECT: complex of the therapeutic measures provides closing the ulcerous defects with no autodermoplasty applied and making the length of treatment 2-3 times as short by the synergetic action of the components of the integrated treatment.
9 cl, 4 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SOFT TISSUES DEFECTS TREATMENT IN PATIENTS WITH DIABETIC FOOT SYNDROME | 2016 |
|
RU2619257C1 |
| METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
| METHOD OF TREATING REPERFUSION SYNDROME IN PATIENTS WITH DIABETES MELLITUS FOLLOWING RE-VASCULARISATION OF LOWER EXTREMITY ARTERIES | 2014 |
|
RU2548739C1 |
| METHOD OF TREATING TROPHIC ULCERS | 2010 |
|
RU2423118C1 |
| METHOD FOR TREATING NEUROISCHEMIC DIABETIC FOOT SYNDROME | 2020 |
|
RU2754415C1 |
| METHOD FOR GENE THERAPY TREATMENT OF DIABETIC FOOT SYNDROME | 2015 |
|
RU2599507C1 |
| MEDICINAL PRODUCT FOR THE TREATMENT OF ULCER DEFECTS IN "DIABETIC FOOT" SYNDROME | 2023 |
|
RU2804781C1 |
| METHOD TO TREAT ULCEROUS DEFECTS AT DIABETIC FOOT SYNDROME | 2000 |
|
RU2178310C1 |
| METHOD OF CLOSING DEFECTS OF LOW-INTENSITY WOUNDS OF LOWER EXTREMITIES IN DIABETIC FOOT SYNDROME | 2015 |
|
RU2608431C1 |
| METHOD OF TREATMENT OF PATIENT WITH DIABETIC FOOT SYNDROME | 1998 |
|
RU2144831C1 |
